Skip to main content
SpringerLink
Log in

Maternal and Fetal Effects of Systemic Therapy in the Pregnant Woman with Cancer

  • Chapter
Cancer and Pregnancy

Part of the book series: Recent Results in Cancer Research ((RECENTCANCER,volume 178))

Abstract

The diagnosis of cancer and the need to administer chemotherapy during pregnancy pose challenges to the woman, her family, and the medical team. The great challenge is to treat the mother without adversely affecting fetal outcome. The relative rarity of pregnancy-associated cancer precludes conducting large prospective studies to examine the safety of the different chemotherapeutic drugs, and the literature is largely composed of small retrospective studies and case reports. In this chapter we critically review available data, controversies, and unresolved issues regarding the administration of chemotherapy during pregnancy and lactation.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Achtari C, Hohlfeld P (2000) Cardiotoxic transplacental effect of idarubicin administered during the second trimester of pregnancy. Am J Obstet Gynecol 183: 511–512

    Article  PubMed  CAS  Google Scholar 

  2. Addar MH (2004) Methotrexate embryopathy in a surviving intrauterine fetus after presumed diagnosis of ectopic pregnancy: case report. J Obstet Gynaecol Can 26: 1001–1003

    PubMed  Google Scholar 

  3. Alegre A, Chunchurreta R, Rodriguez-Alarcon J, Cruz E, Prada M (1982) Successful pregnancy in acute promyelocytic leukemia. Cancer 49: 152–153

    Article  PubMed  CAS  Google Scholar 

  4. Andreadis C, Charalampidou M, Diamantopoulos N, Chouchos N, Mouratidou D (2004) Combined chemotherapy and radiotherapy during conception and first two trimesters of gestation in a woman with metastatic breast cancer. Gynecol Oncol 95: 252–255

    Article  PubMed  Google Scholar 

  5. Arango HA, Kalter CS, Decesare SL, Fiorica JV, Lyman GH, Spellacy WN (1994) Management of chemotherapy in a pregnancy complicated by a large neuroblastoma. Obstet Gynecol 84: 665–668

    PubMed  CAS  Google Scholar 

  6. Artlich A, Moller J, Tschakaloff A, Schwinger E, Kruse K, Gortner L (1994) Teratogenic effects in a case of maternal treatment for acute myelocytic leukaemia--neonatal and infantile course. Eur J Pediatr 153: 488–491

    PubMed  CAS  Google Scholar 

  7. Ault P, Kantarjian H, O’Brien S et al. (2006) Pregnancy among patients with chronic myeloid leukemia treated with imatinib. J Clin Oncol 24: 1204–1208

    Article  PubMed  CAS  Google Scholar 

  8. Aviles A, Diaz-Maqueo JC, Talavera A, Guzman R, Garcia EL (1991) Growth and development of children of mothers treated with chemotherapy during pregnancy: current status of 43 children. Am J Hematol 36: 243–248

    Article  PubMed  CAS  Google Scholar 

  9. Aviles A, Neri N (2001) Hematological malignancies and pregnancy: a final report of 84 children who received chemotherapy in utero. Clin Lymphoma 2: 173–177

    Article  PubMed  CAS  Google Scholar 

  10. Aviles A, Neri N, Nambo MJ (2006) Long-term evaluation of cardiac function in children who received anthracyclines during pregnancy. Ann Oncol 17: 286–288

    Article  PubMed  CAS  Google Scholar 

  11. Ba-Thike K, Oo N (1990) Non-Hodgkin’s lymphoma in pregnancy. Asia Oceania J Obstet Gynaecol 16: 229–232

    PubMed  CAS  Google Scholar 

  12. Bawle EV, Conard JV, Weiss L (1998) Adult and two children with fetal methotrexate syndrome. Teratology 7: 51–55

    Article  Google Scholar 

  13. Brunet S, Sureda A, Mateu R, Domingo-Albos A (1993) Full-term pregnancy in a patient diagnosed with acute leukemia treated with a protocol including VP-16. Med Clin (Barc) 100: 757–758

    CAS  Google Scholar 

  14. Buckley LM, Bullaboy CA, Leichtman L, Marquez M (1997) Multiple congenital anomalies associated with weekly low-dose methotrexate treatment of the mother. Arthritis Rheum 40: 971–973

    Article  PubMed  CAS  Google Scholar 

  15. Caluwaerts S, VAN Calsteren K, Mertens L et al. (2006) Neoadjuvant chemotherapy followed by radical hysterectomy for invasive cervical cancer diagnosed during pregnancy: report of a case and review of the literature. Int J Gynecol Cancer 16: 905–908

    Article  PubMed  CAS  Google Scholar 

  16. Cardonick E, Iacobucci A (2004) Use of chemotherapy during human pregnancy. Lancet Oncol 5: 283–291

    Article  PubMed  CAS  Google Scholar 

  17. Celo JS, Kim HC, Houlihan C, Canavan BF, Manzullo GP, Saidi P (1994) Acute promyelocytic leukemia in pregnancy: all-trans retinoic acid as a newer therapeutic option. Obstet Gynecol 83: 808–811

    PubMed  CAS  Google Scholar 

  18. Choudhary DR, Mishra P, Kumar R, Mahapatra M, Choudhry VP (2006) Pregnancy on imatinib: fatal outcome with meningocele. Ann Oncol 17: 178–179

    Article  PubMed  CAS  Google Scholar 

  19. Claahsen HL, Semmekrot BA, van Dongen PW, Mattijssen V (1998) Successful fetal outcome after exposure to idarubicin and cytosine-arabinoside during the second trimester of pregnancy—a case report. Am J Perinatol 15: 295–297

    PubMed  CAS  Google Scholar 

  20. Colbert N, Najman A, Gorin NC et al. (1980) Acute leukaemia during pregnancy: favourable course of pregnancy in two patients treated with cytosine arabinoside and anthracyclines. Nouv Presse Med 9: 175–178

    PubMed  CAS  Google Scholar 

  21. Dara P, Slater LM, Armentrout SA (1981) Successful pregnancy during chemotherapy for acute leukemia. Cancer 47: 845–846

    Article  PubMed  CAS  Google Scholar 

  22. Delgado-Lamas JL, Garces-Ruiz OM (2000) Acute promyelocytic leukemia in late pregnancy. successful treatment with all-trans-retinoic acid (ATRA) and chemotherapy. Hematology 4: 415–418

    PubMed  Google Scholar 

  23. DeLoia JA, Stewart-Akers AM, Creinin MD (1998) Effects of methotrexate on trophoblast proliferation and local immune responses. Hum Reprod 13: 1063–1069

    Article  PubMed  CAS  Google Scholar 

  24. Diniz EM, Corradini HB, Ramos JL, Brock R (1978) Effect on the fetus of methotrexate (amethopterin) administered to the mother. Presentation of a case. Rev Hosp Clin Fac Med Sao Paulo 33: 286–290

    PubMed  CAS  Google Scholar 

  25. Doll DC, Ringenberg QS, Yarbro JW (1998) Management of cancer during pregnancy. Arch Intern Med 148: 2058–2064

    Article  Google Scholar 

  26. Donnenfeld AE, Pastuszak A, Noah JS, Schick B, Rose NC, Koren G (1994) Methotrexate exposure prior to and during pregnancy. Teratology 49: 79–81

    Article  PubMed  CAS  Google Scholar 

  27. Durodola JI (1979) Administration of cyclophosphamide during late pregnancy and early lactation: a case report. J Natl Med Assoc 71: 165–166

    PubMed  CAS  Google Scholar 

  28. Elit L, Bocking A, Kenyon C, Natale R (1999) An endodermal sinus tumor diagnosed during pregnancy: case report and review of the literature. Gynecol Oncol 72: 123–127

    Article  PubMed  CAS  Google Scholar 

  29. Falkson HC, Simson IW, Falkson G (1980) Non-Hodgkin’s lymphoma in pregnancy. Cancer 45: 1679–1682

    Article  PubMed  CAS  Google Scholar 

  30. Fanale MA, Uyei AR, Theriault RL, Adam K (2005) Treatment of metastatic breast cancer with trastuzumab and vinorelbine during pregnancy. Clin Breast Cancer 6: 354–356

    PubMed  CAS  Google Scholar 

  31. Feliu J, Juarez S, Ordonez A, Garcia-Paredes ML, Gonzalez-Baron M, Montero JM (1988) Acute leukemia and pregnancy. Cancer 61: 580–584

    Article  PubMed  CAS  Google Scholar 

  32. Ferrandina G, Distefano M, Testa A, De Vincenzo R, Scambia G (2005) Management of an advanced ovarian cancer at 15 weeks of gestation: case report and literature review. Gynecol Oncol 97: 693–696

    Article  PubMed  Google Scholar 

  33. Friedrichs B, Tiemann M, Salwender H, Verpoort K, Wenger MK, Schmitz N. (2006) The effects of rituximab treatment during pregnancy on a neonate. Haematologica 91: 1426–1427

    Google Scholar 

  34. Gadducci A, Cosio S, Fanucchi A et al. (2003) Chemotherapy with epirubicin and paclitaxel for breast cancer during pregnancy: case report and review of the literature. Anticancer Res 23: 5225–5229

    PubMed  Google Scholar 

  35. Gililland J, Weinstein L (1983) The effects of cancer chemotherapeutic agents on the developing fetus. Obstet Gynecol Surv 38: 6–13

    PubMed  CAS  Google Scholar 

  36. Gonzalez-Angulo AM, Walters RS, Carpenter RJ Jr et al. (2004) Paclitaxel chemotherapy in a pregnant patient with bilateral breast cancer. Clin Breast Cancer 5: 317–319.

    PubMed  Google Scholar 

  37. Greenberg LH, Tanaka KR (1964) Congenital anomalies probably induced by cyclophosphamide. JAMA 188: 423–426

    PubMed  CAS  Google Scholar 

  38. Hahn KM, Johnson PH, Gordon N et al. (2006) Treatment of pregnant breast cancer patients and outcomes of children exposed to chemotherapy in utero. Cancer 107: 1219–1226

    Article  PubMed  Google Scholar 

  39. Harrison P, Chipping P, Fothergill GA (1994) Successful use of all-trans retinoic acid in acute promyelocytic leukaemia presenting during the second trimester of pregnancy. Br J Haematol 86: 681–682

    PubMed  CAS  Google Scholar 

  40. Henderson CH, Elia G, Garfinkel D et al. (1993) Platinum chemotherapy during pregnancy for cystadenocarcinoma of the ovary. Gynecol Oncol 49: 9–94

    Article  Google Scholar 

  41. Hiratsuka M, Minakami H, Koshizuka S, Sato I (2000) Administration of interferon-alpha during pregnancy: effects on fetus. J Perinat Med 28: 372–376

    Article  PubMed  CAS  Google Scholar 

  42. Horbelt D, Delmore J, Meisel R, Cho S, Roberts D, Logan D (1994) Mixed germ cell malignancy of the ovary concurrent with pregnancy. Obstet Gynecol 84: 662–664

    PubMed  CAS  Google Scholar 

  43. Huang HP, Fang CN, Kan YY (2004) Chemotherapy for ovarian mucinous cystadenocarcinoma during pregnancy: a case report. Eur J Gynaecol Oncol 25: 635–636.

    PubMed  Google Scholar 

  44. Incerpi MH, Miller DA, Posen R, Byrne JD (1997) All-trans retinoic acid for the treatment of acute promyelocytic leukemia in pregnancy. Obstet Gynecol 89: 826–828

    Article  PubMed  CAS  Google Scholar 

  45. Isaacs RJ, Hunter W, Clark K (2001) Tamoxifen as systemic treatment of advanced breast cancer during pregnancy—case report and literature review. Gynecol Oncol 80: 405–408

    Article  PubMed  CAS  Google Scholar 

  46. Jacobs C, Donaldson SS, Rosenberg SA, Kaplan HS (1981) Management of the pregnant patient with Hodgkin’s disease. Ann Intern Med 95: 669–775

    PubMed  CAS  Google Scholar 

  47. Kimby E, Sverrisdottir A, Elinder G (2004) Safety of rituximab therapy during the first trimester of pregnancy: a case history. Eur J Haematol 72: 292–295

    Article  PubMed  Google Scholar 

  48. Kirshon B, Wasserstrum N, Willis R, Herman GE, McCabe ER (1988) Teratogenic effects of first-trimester cyclophosphamide therapy. Obstet Gynecol 72: 462–464.

    PubMed  CAS  Google Scholar 

  49. Koren G, Lishner M, Santiago S (2005) The Motherisk guide to cancer in pregnancy and lactation (2nd edition). Motherisk program, Toronto, Canada.

    Google Scholar 

  50. Kozlowski RD, Steinbrunner JV, MacKenzie AH, Clough JD, Wilke WS, Segal AM (1990) Outcome of first-trimester exposure to low-dose methotrexate in eight patients with rheumatic disease. Am J Med 88: 589–592

    Article  PubMed  CAS  Google Scholar 

  51. Leslie KK, Koil C, Rayburn WF (2005) Chemotherapeutic drugs in pregnancy. Obstet Gynecol Clin North Am 32: 627–640

    Article  PubMed  Google Scholar 

  52. Lishner M, Zemlickis D, Degendorfer P, Panzarella T, Sutcliffe SB, Koren G (1992) Maternal and fetal outcome following Hodgkin’s disease in pregnancy. Br J Cancer 65: 114–117

    PubMed  CAS  Google Scholar 

  53. Matalon ST, Ornoy A, Lishner M (2004) Review of the potential effects of three commonly used antineoplastic and immunosuppressive drugs (cyclophosphamide, azathioprine, doxorubicin) on the embryo and placenta. Reprod Toxicol 18: 219–230

    Article  PubMed  CAS  Google Scholar 

  54. Matalon ST, Ornoy A, Lishner M (2005) The effect of 6-mercaptopurine on early human placental explants. Hum Reprod 20: 1390–1397

    Article  PubMed  CAS  Google Scholar 

  55. Matsuo K, Shimoya K, Ueda S, Wada K, Koyama M, Murata Y (2004) Idarubicin administered during pregnancy: its effects on the fetus. Gynecol Obstet Invest 58: 186–188

    Article  PubMed  CAS  Google Scholar 

  56. Maurer LH, Forcier RJ, McIntyre OR, Benirschke K (1971) Fetal group C trisomy after cytosine arabinoside and thioguanine. Ann Intern Med 75: 809–810

    PubMed  CAS  Google Scholar 

  57. Mendez LE, Mueller A, Salom E, Gonzalez-Quintero VH (2003) Paclitaxel and carboplatin chemotherapy administered during pregnancy for advanced epithelial ovarian cancer. Obstet Gynecol 102: 1200–1202

    Article  PubMed  Google Scholar 

  58. Merimsky O, Le Chevalier T, Missenard G et al. (1999) Management of cancer in pregnancy: a case of Ewing’s sarcoma of the pelvis in the third trimester. Ann Oncol 10: 345–350

    Article  PubMed  CAS  Google Scholar 

  59. Milunsky A, Graef JW, Gaynor MF Jr (1968) Methotrexate-induced congenital malformations. J Pediatr 72: 790–795

    Article  PubMed  CAS  Google Scholar 

  60. Mulvihill JJ, McKeen EA, Rosner F, Zarrabi MH (1987) Pregnancy outcome in cancer patients. Experience in a large cooperative group. Cancer 60: 1143–1150

    Article  PubMed  CAS  Google Scholar 

  61. Murray CL, Reichert JA, Anderson J, Twiggs LB (1984) Multimodal cancer therapy for breast cancer in the first trimester of pregnancy. A case report. JAMA 252: 2607–2608

    Article  PubMed  CAS  Google Scholar 

  62. Murray NA, Acolet D, Deane M, Price J, Roberts IA (1994) Fetal marrow suppression after maternal chemotherapy for leukaemia. Arch Dis Child Fetal Neonatal Ed 71: F209–F210

    PubMed  CAS  Google Scholar 

  63. Nakajima W, Ishida A, Takahashi M et al. (2004) Good outcome for infant of mother treated with chemotherapy for ewing sarcoma at 25 to 30 weeks’ gestation. J Pediatr Hematol Oncol 26: 308–311

    Article  PubMed  Google Scholar 

  64. Nicholson HO (1968) Cytotoxic drugs in pregnancy. Review of reported cases. J Obstet Gynaecol Br Commonw 75: 307–312

    PubMed  CAS  Google Scholar 

  65. Niedermeier DM, Frei-Lahr DA, Hall PD (2005) Treatment of acute myeloid leukemia during the second and third trimesters of pregnancy. Pharmacotherapy 25: 1134–1140

    Article  PubMed  Google Scholar 

  66. Nulman I, Laslo D, Fried S, Uleryk E, Lishner M, Koren G (2001) Neurodevelopment of children exposed in utero to treatment of maternal malignancy. Br J Cancer 85: 1611–1618

    Article  PubMed  CAS  Google Scholar 

  67. O’Donnell R, Costigan C, O’Connell LG (1979) Two cases of acute leukaemia in pregnancy. Acta Haematol 61: 298–300

    PubMed  CAS  Google Scholar 

  68. Ojeda-Uribe M, Gilliot C, Jung G, Drenou B, Brunot A (2006) Administration of rituximab during the first trimester of pregnancy without consequences for the newborn. J Perinatol 26: 252–255

    Article  PubMed  CAS  Google Scholar 

  69. Ortega J (1977) Multiple agent chemotherapy including bleomycin of non-Hodgkin’s lymphoma during pregnancy. Cancer 40: 2829–2835

    Article  PubMed  CAS  Google Scholar 

  70. Pacifici GM, Nottoli R (1995) Placental transfer of drugs administered to the mother. Clin Pharmacokinet 28: 235–269

    PubMed  CAS  Google Scholar 

  71. Pizzuto J, Aviles A, Noriega L, Niz J, Morales M, Romero F (1980) Treatment of acute leukemia during pregnancy: presentation of nine cases. Cancer Treat Rep 64: 679–683

    PubMed  CAS  Google Scholar 

  72. Powell HR, Ekert H (1971) Methotrexate-induced congenital malformations. Med J Aust 2: 1076–1077

    PubMed  CAS  Google Scholar 

  73. Prabhash K, Sastry PS, Biswas G et al. (2005) Pregnancy outcome of two patients treated with imatinib. Ann Oncol 16: 1983–1984

    Article  PubMed  CAS  Google Scholar 

  74. Raffles A, Williams J, Costeloe K, Clark P (1989) Transplacental effects of maternal cancer chemotherapy. Case report. Br J Obstet Gynaecol 96: 1099–1100

    PubMed  CAS  Google Scholar 

  75. Randall T (1993) National registry seeks scarce data on pregnancy outcomes during chemotherapy. JAMA 269: 323

    Article  PubMed  CAS  Google Scholar 

  76. Reynoso EE, Shepherd FA, Messner HA, Farquharson HA, Garvey MB, Baker MA (1987) Acute leukemia during pregnancy: the Toronto Leukemia Study Group experience with long-term follow-up of children exposed in utero to chemotherapeutic agents. J Clin Oncol 5: 1098–1106

    PubMed  CAS  Google Scholar 

  77. Scully M, Starke R, Lee R, Mackie I, Machin S, Cohen H (2006) Successful management of pregnancy in women with a history of thrombotic thrombocytopaenic purpura. Blood Coagul Fibrinolysis 17: 459–463

    Article  PubMed  Google Scholar 

  78. Shoton D, Monie IW (1963) Possible teratogenic effect of chlorambucil on a human fetus. JAMA 186: 180–181

    Google Scholar 

  79. Siu BL, Alonzo MR, Vargo TA, Fenrich AL (2002) Transient dilated cardiomyopathy in a newborn exposed to idarubicin and all-trans-retinoic acid (ATRA) early in the second trimester of pregnancy. Int J Gynecol Cancer 12: 399–402

    Article  PubMed  CAS  Google Scholar 

  80. Sood AK, Shahin MS, Sorosky JI (2001) Paclitaxel and platinum chemotherapy for ovarian carcinoma during pregnancy. Gynecol Oncol 83: 599–600

    Article  PubMed  CAS  Google Scholar 

  81. Sorosky JI, Sood AK, Buekers TE (1997) The use of chemotherapeutic agents during pregnancy. Obstet Gynecol Clin North Am 24: 591–599

    Article  PubMed  CAS  Google Scholar 

  82. Steege JF, Caldwell DS (1980) Renal agenesis after first trimester exposure to chlorambucil. South Med J 73: 1414–1415

    PubMed  CAS  Google Scholar 

  83. Stentoft J, Nielsen JL, Hvidman LE (1994) All-trans retinoic acid in acute promyelocytic leukemia in late pregnancy. Leukemia 8: 1585–1588

    PubMed  CAS  Google Scholar 

  84. Taylor G, Blom J (1980) Acute leukemia during pregnancy. South Med J 73: 1314–1315

    PubMed  CAS  Google Scholar 

  85. Toledo TM, Harper RC, Moser RH (1971) Fetal effects during cyclophosphamide and irradiation therapy. Ann Intern Med 74: 87–91

    PubMed  CAS  Google Scholar 

  86. Vantroyen B, Vanstraelen D (2002) Management of essential thrombocythemia during pregnancy with aspirin, interferon alpha-2a and no treatment. A comparative analysis of the literature. Acta Haematol 107: 158–169

    Article  PubMed  CAS  Google Scholar 

  87. Volkenandt M, Buchner T, Hiddemann W, Van de Loo J (1987) Acute leukaemia during pregnancy. Lancet 2: 1521–1522

    Article  PubMed  CAS  Google Scholar 

  88. Watson WJ (2005) Herceptin (trastuzumab) therapy during pregnancy: association with reversible anhydramnios. Obstet Gynecol 105: 642–643

    PubMed  Google Scholar 

  89. Weisz B, Meirow D, Schiff E, Lishner M (2004) Impact and treatment of cancer during pregnancy. Expert Rev Anticancer Ther 4: 889–902

    Article  PubMed  Google Scholar 

  90. Zemlickis D, Lishner M, Degendorfer P, Panzarella T, Sutcliffe SB, Koren G (1992) Fetal outcome after in utero exposure to cancer chemotherapy. Arch Intern Med 152: 573–576

    Article  PubMed  CAS  Google Scholar 

  91. Zemlickis D, Lishner M, Erlich R, Koren G (1993) Teratogenicity and carcinogenicity in a twin exposed in utero to cyclophosphamide. Teratog Carcinog Mutagen 13: 139–143

    Article  PubMed  CAS  Google Scholar 

  92. Zuazu J, Julia A, Sierra J et al. (1991) Pregnancy outcome in hematologic malignancies. Cancer 67: 703–709.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine A, Meir Medical Center, 44281, Kfar Sava , Israel

    David Pereg & Michael Lishner

Authors
  1. David Pereg
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michael Lishner
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Pereg, D., Lishner, M. (2008). Maternal and Fetal Effects of Systemic Therapy in the Pregnant Woman with Cancer. In: Cancer and Pregnancy. Recent Results in Cancer Research, vol 178. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-71274-9_3

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-71274-9_3

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-71272-5

  • Online ISBN: 978-3-540-71274-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation